Bonus Biogroup (Israel) Investor Sentiment

BONS Stock  ILS 17.70  0.10  0.57%   
About 54% of Bonus Biogroup's investors are presently thinking to get in. The analysis of current outlook of investing in Bonus Biogroup suggests that some traders are interested regarding Bonus Biogroup's prospects. The current market sentiment, together with Bonus Biogroup's historical and current headlines, can help investors time the market. In addition, many technical investors use Bonus Biogroup stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Bonus Biogroup Announces U.S. Food and Drug Administration Clearance of an Investigational New Drug ...
Google News at Macroaxis
over two weeks ago at news.google.com         
Bonus Biogroup Gains FDA Approval for Crucial Phase III ARDS Drug Trial - MSN
Google News at Macroaxis
over two weeks ago at news.google.com         
Court Approves Bonus Biogroups Warrant Extension Request - TipRanks
Google News at Macroaxis
over three weeks ago at news.google.com         
Bonus Biogroup Announces Upcoming General Meeting - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
February 2025s Promising Penny Stocks For Savvy Investors - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Oriola Oyj And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Bonus BioGroup Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 3...
Google News at Macroaxis
over six months ago at news.google.com         
Biotech firm grows bone from your own tissue for seamless healing - NoCamels - Israeli Innovation Ne...
Google News at Macroaxis
over six months ago at news.google.com         
Were Keeping An Eye On Bonus BioGroups Cash Burn Rate - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Will Bonus BioGroup Spend Its Cash Wisely - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Novacyt Sanction judiciaire du plan darrangement -Le 07 ... - Zonebourse.com
Google News at Macroaxis
over a year ago at news.google.com         
Bonus BioGroup Company Presentation, July 2023 - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Yourgene Health accepte loffre dacquisition de Novacyt pour un ... - Zonebourse.com
Google News at Macroaxis
over a year ago at news.google.com         
Were Keeping An Eye On Bonus BioGroups Cash Burn Rate - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Bonus Biogroup that are available to investors today. That information is available publicly through Bonus media outlets and privately through word of mouth or via Bonus internal channels. However, regardless of the origin, that massive amount of Bonus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bonus Biogroup news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bonus Biogroup relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bonus Biogroup's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bonus Biogroup alpha.

Bonus Biogroup Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Bonus Stock analysis

When running Bonus Biogroup's price analysis, check to measure Bonus Biogroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus Biogroup is operating at the current time. Most of Bonus Biogroup's value examination focuses on studying past and present price action to predict the probability of Bonus Biogroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus Biogroup's price. Additionally, you may evaluate how the addition of Bonus Biogroup to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine